Contact us

  • View funds and model portfolios

    Learn more about our investment products

    How to invest with us

  • Latest insights""Events and webinars""Vanguard outlook 2026""
  • Discover Vanguard 365""

    Learn and earn CPD

    In-depth research for advisers

    Tools and resources for advisers

  • About Vanguard""Contact us""Fraud prevention""

    Corporate reports

    • Global Stock Index Fund - Institutional Plus GBP Acc (VANIPGA)

    Available in other share classes
    Related Documents
    NAV Price ()
    —
    Number of stocks
    —
    —
    Risk Indicator
    —

    About this fund

    Fund objectives

    • The Fund employs a passive management – or indexing – investment approach and seeks to provide long-term capital growth by tracking the performance of the MSCI World Index (the “Index”).
    • The Index is comprised of large and mid-sized company stocks in developed markets.
    • The Fund attempts to: 1. Track the performance of the Index by investing in all constituent securities of the Index in the same proportion as the Index. Where not practicable to fully replicate, the Fund will use a sampling process. 2. Remain fully invested except in extraordinary market, political or similar conditions.

    Fund facts

    Share class inception
    14 Dec 2017
    Minimum initial investment
    £100,000,000.00
    Investment structure
    Irish UCITS
    Share Class Assets'
    Total Assets
    Strategy
    Index
    Asset Class
    Equity
    Domicile
    Ireland
    Dividend schedule
    —
    Tax status
    Germany,United Kingdom reporting
    Currency
    GBP
    Legal entity
    Vanguard Investment Series PLC
    Investment manager

    Global Equity Index Management (GE)

    Benchmark
    MSCI World Index

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Performance

    Risk and Volatility

    As at 31 Mar 2026

    Beta
    R²
    Annualized Tracking Error
    1 year
    3 years
    5 years

    Please note Beta and R-squared data will only display for funds with 3 full years of history.

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Portfolio data

    Characteristics
    FundamentalsFundBenchmarkAs at
    Number of stocks 1,326 1,310 31 Mar 2026
    Median market capital 129.8 B 131.2 B 31 Mar 2026
    23.1 x 23.1 x 31 Mar 2026
    3.6 x 3.6 x 31 Mar 2026
    19.6% 19.6% 31 Mar 2026
    21.1% 21.0% 31 Mar 2026
    Portfolio turnover rate -32.9% — 31 Mar 2026

    Market allocation

    As at 31 Mar 2026

    CountryRegionFundBenchmarkVariance +/-
    United States of AmericaNorth America 71.27% 71.31% -0.04%
    JapanPacific 5.69% 5.70% -0.01%
    United KingdomEurope 3.84% 3.78% 0.06%
    CanadaNorth America 3.58% 3.58% 0.00%
    FranceEurope 2.57% 2.58% -0.01%
    SwitzerlandEurope 2.35% 2.36% -0.01%
    GermanyEurope 2.27% 2.28% -0.01%
    AustraliaPacific 1.68% 1.68% 0.00%
    NetherlandsEurope 1.31% 1.31% 0.00%
    SpainEurope 0.98% 0.98% 0.00%
    SwedenEurope 0.91% 0.91% 0.00%
    ItalyEurope 0.82% 0.82% 0.00%
    Hong KongPacific 0.52% 0.52% 0.00%
    SingaporePacific 0.44% 0.43% 0.01%
    DenmarkEurope 0.42% 0.42% 0.00%

    Holdings details

    As at 31 Mar 2026

    Holding name% of market valueSectorRegionMarket valueShares
    NVIDIA Corp 5.27517% Information Technology US £1,193,518,608.00 6,843,570
    Apple Inc 4.64413% Information Technology US £1,050,745,926.22 4,140,218
    Microsoft Corp 3.25289% Information Technology US £735,974,215.02 1,988,206
    Amazon.com Inc 2.49399% Consumer Discretionary US £564,272,159.10 2,709,330
    Alphabet Inc 2.08313% Communication Services US £471,312,277.80 1,639,005
    Alphabet Inc 1.73738% Communication Services US £393,085,692.30 1,370,305
    Broadcom Inc 1.73505% Information Technology US £392,558,342.22 1,268,322
    Meta Platforms Inc 1.55067% Communication Services US £350,842,702.86 613,222
    Tesla Inc 1.30778% Consumer Discretionary US £295,888,092.75 795,933
    Eli Lilly & Co 0.91988% Health Care US £208,125,555.60 226,280

    Total allocation percentages shown in the holdings details or the spreadsheet may not equal 100%, due to rounding or omission of cash and/or derivative instruments.

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Weighted equity exposures exclude any temporary cash investments and equity index derivatives.

    Prices and distribution

    Prices

    NAV Price (GBP)
    £251.39
    Change
    -£1.52-0.60%
    At closure 21 Apr 2026
    NAV 52-week high
    £252.91
    At closure 22 Apr 2026
    NAV 52-week low
    £194.21
    At closure 22 Apr 2026
    NAV 52-week difference
    £58.70
    Change
    +23.21%
    At closure 22 Apr 2026
    Historical Prices

    -

    Inception date

    14 Dec 2017

    Date NAV (GBP)
    21 Apr 2026 £251.3852
    20 Apr 2026 £252.9069
    17 Apr 2026 £252.7911
    16 Apr 2026 £250.6914
    15 Apr 2026 £249.3882
    14 Apr 2026 £247.7508
    13 Apr 2026 £246.7667
    10 Apr 2026 £245.0983
    09 Apr 2026 £245.7570
    08 Apr 2026 £244.4510

    Distribution history

    Distribution frequency

    —

    Historical performance 31 Mar 2026

    1.24%

    All dividends are reinvested for the "Accumulation" shares.

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Purchase information

    Currency

    Base currency: GBP

    Fund codes

    • Bloomberg: VANIPGA
    • Citi: OB9T
    • ISIN: IE00BYVQ3L68
    • MEX ID: VINMA
    • SEDOL: BYVQ3L6

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    SEDOL and SEDOL Masterfile® are registered trademarks of the London Stock Exchange Group PLC. SEDOL data was extracted from the London Stock Exchange SEDOL Masterfile®.